Observational analysis evaluates antioxidant activity in acyl derivatives, suggesting potential for drug development.
Key Points
Methyl ester of 1β,4α-dihydroxy-2,3-dihydroquinopimaric acid reveals effective antioxidant activity in both FRAP and ABTS models.
Four synthesized acylates show a significantly higher reducing potential compared to their parent compounds, indicating their enhanced antioxidant abilities.
Synthesis involved acylation of methyl esters using DMAP as a catalyst, confirmed by NMR spectroscopy and mass spectrometry.
Findings highlight the need for further optimization and assessment of metabolic stability and bioavailability in developing antioxidant drugs.